Inconsistent application of intellectual property rights and regulations
Trade barrier summary
Through the issuance of Decree 321, Intellectual Property (IP) protection for pharmaceutical products has seen progress. However, previously there has been inconsistent application of IP protection as UAE have insisted that innovation that innovator companies start filing for national patents, rather than recognising Country of Origin patents.
Sectors affected
- Pharmaceuticals and biotechnology
Resolved
No
Date reported
13 May 2019
Last updated
25 November 2021
Public ID
PID-BQ6RZB
If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .
If you export goods you can check duties and customs procedures for your chosen market.